Search research articles
Contact Us
Filters
Showing results (11-20 of 98) with videos related to
Page
of 10
Sort By:
Current Treatment Options in Oncology
|
June 9, 2023
RAS and Other Molecular Targets in Pancreatic Cancer: The Next Wave Is Coming
Lisa Miller-Phillips, Eric A Collisson
Trends in Pharmacological Sciences
|
December 2, 2020
Ferrous Iron-Dependent Pharmacology
Ryan L Gonciarz, Eric A Collisson, Adam R Renslo
Nature Reviews. Clinical Oncology
|
September 12, 2012
What are we learning from the cancer genome?
Eric A Collisson, Raymond J Cho, Joe W Gray
Journal of the National Comprehensive Cancer Network : JNCCN
|
July 12, 2016
The Authors Respond
Jocelyn S Chapman, Eric A Collisson, Barry S Taylor
Nature Reviews. Gastroenterology & Hepatology
|
February 6, 2019
Molecular subtypes of pancreatic cancer
Eric A Collisson, Peter Bailey, David K Chang, et al.
The Journal of Investigative Dermatology
|
November 26, 2002
Isoprenylation is necessary for the full invasive potential of RhoA overexpression in human melanoma cells
Eric A Collisson, Dafnis C Carranza, Ingrid Y Chen, et al.
JAMA Network Open
|
June 8, 2022
Comparison of FOLFIRINOX vs Gemcitabine Plus Nab-Paclitaxel as First-Line Chemotherapy for Metastatic Pancreatic Ductal Adenocarcinoma
Avital Klein-Brill, Shlomit Amar-Farkash, Gabriella Lawrence, et al.
Cancer Research
|
October 3, 2003
Treatment of metastatic melanoma with an orally available inhibitor of the Ras-Raf-MAPK cascade
Eric A Collisson, Abhijit De, Hiroyuki Suzuki, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 10, 2016
Re: "Clinical Sequencing Contributes to a BRCA-Associated Cancer Rediagnosis That Guides an Effective Therapeutic Course"
Frederick Klauschen, Hendrik Bläker, Albrecht Stenzinger, et al.
Biochemical Society Transactions
|
April 16, 2021
State of the structure address on MET receptor activation by HGF
Edmond M Linossi, Gabriella O Estevam, Masaya Oshima, et al.
Page
of 10
Search research articles
Search
Showing results (11-20 of 98) with videos related to
Sort By:
Page
of 10
Current Treatment Options in Oncology
|
June 9, 2023
RAS and Other Molecular Targets in Pancreatic Cancer: The Next Wave Is Coming
Lisa Miller-Phillips, Eric A Collisson
Trends in Pharmacological Sciences
|
December 2, 2020
Ferrous Iron-Dependent Pharmacology
Ryan L Gonciarz, Eric A Collisson, Adam R Renslo
Nature Reviews. Clinical Oncology
|
September 12, 2012
What are we learning from the cancer genome?
Eric A Collisson, Raymond J Cho, Joe W Gray
Journal of the National Comprehensive Cancer Network : JNCCN
|
July 12, 2016
The Authors Respond
Jocelyn S Chapman, Eric A Collisson, Barry S Taylor
Nature Reviews. Gastroenterology & Hepatology
|
February 6, 2019
Molecular subtypes of pancreatic cancer
Eric A Collisson, Peter Bailey, David K Chang, et al.
The Journal of Investigative Dermatology
|
November 26, 2002
Isoprenylation is necessary for the full invasive potential of RhoA overexpression in human melanoma cells
Eric A Collisson, Dafnis C Carranza, Ingrid Y Chen, et al.
JAMA Network Open
|
June 8, 2022
Comparison of FOLFIRINOX vs Gemcitabine Plus Nab-Paclitaxel as First-Line Chemotherapy for Metastatic Pancreatic Ductal Adenocarcinoma
Avital Klein-Brill, Shlomit Amar-Farkash, Gabriella Lawrence, et al.
Cancer Research
|
October 3, 2003
Treatment of metastatic melanoma with an orally available inhibitor of the Ras-Raf-MAPK cascade
Eric A Collisson, Abhijit De, Hiroyuki Suzuki, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 10, 2016
Re: "Clinical Sequencing Contributes to a BRCA-Associated Cancer Rediagnosis That Guides an Effective Therapeutic Course"
Frederick Klauschen, Hendrik Bläker, Albrecht Stenzinger, et al.
Biochemical Society Transactions
|
April 16, 2021
State of the structure address on MET receptor activation by HGF
Edmond M Linossi, Gabriella O Estevam, Masaya Oshima, et al.
Page
of 10